# Fast Evaluation: CRDO

**Backend:** ai_hedge_fund
**Consensus:** 🔴 Bearish (-0.3900)
**Period:** 2026-03-03 → 2026-06-01

---

## Analyst Opinions

| | Count | Pct |
|---|---|---|
| 🟢 Bullish | 3 | 16% |
| 🔴 Bearish | 9 | 47% |
| 🟡 Neutral | 7 | 37% |

### 🟢 sentiment_analyst_agent — BULLISH (confidence: 100%)

{'insider_trading': {'signal': 'bullish', 'confidence': 100, 'metrics': {'total_trades': 150, 'bullish_trades': 150, 'bearish_trades': 0, 'weight': 0.3, 'weighted_bullish': 45.0, 'weighted_bearish': 0.0}}, 'news_sentiment': {'signal': 'neutral', 'confidence': 0, 'metrics': {'total_articles': 0, 'bullish_articles': 0, 'bearish_articles': 0, 'neutral_articles': 0, 'weight': 0.7, 'weighted_bullish': 0.0, 'weighted_bearish': 0.0}}, 'combined_analysis': {'total_weighted_bullish': 45.0, 'total_weighted_bearish': 0.0, 'signal_determination': 'Bullish based on weighted signal comparison'}}

### 🟢 news_sentiment_agent — BULLISH (confidence: 78%)

{'news_sentiment': {'signal': 'bullish', 'confidence': 77.5, 'metrics': {'total_articles': 5, 'bullish_articles': 3, 'bearish_articles': 0, 'neutral_articles': 2, 'articles_classified_by_llm': 5}}}

### 🟢 technical_analyst_agent — BULLISH (confidence: 21%)

{'summary': 'Trend bullish (ADX 39.5); MeanRev neutral (RSI 65.2, z=1.77); Momentum neutral (1m mom +33.5%); Vol neutral (HV 0.99). → BULLISH at 21% confidence.', 'trend_following': {'signal': 'bullish', 'confidence': 39, 'metrics': {'adx': 39.49174190475872, 'trend_strength': 0.3949174190475872}}, 'mean_reversion': {'signal': 'neutral', 'confidence': 50, 'metrics': {'z_score': 1.7733312779301758, 'price_vs_bb': 0.993043158781205, 'rsi_14': 65.20848519366636, 'rsi_28': 61.45165882190487}}, 'momentum': {'signal': 'neutral', 'confidence': 50, 'metrics': {'momentum_1m': 0.3348132452482655, 'momentum_3m': 0.0, 'momentum_6m': 0.0, 'volume_momentum': 1.196672634382778}}, 'volatility': {'signal': 'neutral', 'confidence': 50, 'metrics': {'historical_volatility': 0.9867799843069737, 'volatility_regime': 0.0, 'volatility_z_score': 0.0, 'atr_ratio': 0.08154804179719262}}, 'statistical_arbitrage': {'signal': 'neutral', 'confidence': 50, 'metrics': {'hurst_exponent': 4.4162737839765496e-15, 'skewness': 0.0, 'kurtosis': 0.0}}}

### 🔴 valuation_analyst_agent — BEARISH (confidence: 100%)

{'dcf_analysis': {'signal': 'bearish', 'details': 'Value: $3,649,252,385.02, Market Cap: $43,535,716,352.00, Gap: -91.6%, Weight: 35%\n  WACC: 10.5%, Bear: $2,790,817,674.82, Bull: $4,373,241,786.03, Range: $1,582,424,111.20'}, 'ev_ebitda_analysis': {'signal': 'neutral', 'details': 'Value: $43,535,716,000.00, Market Cap: $43,535,716,352.00, Gap: -0.0%, Weight: 20%'}, 'dcf_scenario_analysis': {'bear_case': '$2,790,817,674.82', 'base_case': '$3,694,067,488.09', 'bull_case': '$4,373,241,786.03', 'wacc_used': '10.5%', 'fcf_periods_analyzed': 8}}

### 🔴 ben_graham_agent — BEARISH (confidence: 95%)

The stock is severely overvalued relative to its net current asset value, providing no margin of safety—a cornerstone of Graham’s approach. The price per share of $240.32 is approximately 74 times the NCAV per share of $3.23, far exceeding any reasonable floor of value. Moreover, the earnings analysis yields no score due to a lack of multi-year EPS data, failing Graham’s insistence on stable, proven earnings. The inability to compute a Graham Number because EPS or book value is missing or negative further underscores the speculative nature of this investment. While the financial strength is adequate—current ratio of 6.62 (well above the 2.0 minimum) and a conservative debt ratio of 0.16—these factors alone cannot justify the price in the absence of demonstrated earning power and a tangible asset backing. No dividend history adds to the risk. Given the extreme disconnect between price and liquidation value, and the absence of fundamental earnings support, a bearish stance is warranted.

### 🔴 bill_ackman_agent — BEARISH (confidence: 90%)

CRDO exhibits all the hallmarks of a speculative growth stock that Ackman would avoid. Despite stellar revenue growth of 644%, the business fails to generate consistent positive free cash flow and operates with an average operating margin of -17.1% — unacceptable for a high-quality compounder. The balance sheet shows reasonable leverage, but there is zero evidence of shareholder-friendly capital allocation: no dividends, no buybacks, and shares outstanding have not decreased. The only bright spot is a high ROE of 27.5%, yet this appears driven by an abnormally low equity base rather than a sustainable competitive moat. Valuation is catastrophic: our intrinsic value estimate of $1.1 billion is dwarfed by the $43.5 billion market cap, implying a negative 97.5% margin of safety. Even if an activist could unlock margin improvements, the stock is so grossly overvalued that any operational fix would be insufficient to justify current prices. This is a classic 'too hard' pile candidate. Strong convictions demand a bearish call — avoid until the price reflects economic reality.

### 🔴 mohnish_pabrai_agent — BEARISH (confidence: 90%)

CRDO's balance sheet is fortress-like (net cash $220M, D/E 0.02, current ratio 6.62), offering strong financial downside protection against bankruptcy. However, the free cash flow yield is practically zero (0.0000055%), meaning the current price offers no cash return. The business is capex-heavy (11.9% of revenue) and despite 271% revenue growth, normalized FCF is negligible ($2,400). Without meaningful cash generation, intrinsic value is uncertain. Doubling potential over 2-3 years is unlikely given the rich valuation. This fails the core Pabrai principle of demanding high FCF yields and a significant margin of safety; 'tails I lose much' is the risk here. Avoid.

### 🔴 rakesh_jhunjhunwala_agent — BEARISH (confidence: 80%)

Arre bhai, this stock is trading at over 15 times its intrinsic value! I can’t even begin to find any margin of safety here—it’s negative 93%, which is a disaster for a value investor. Sure, the top line is growing at 28% CAGR, and the bottom line has exploded, but growth alone doesn’t justify such madness, especially when it’s inconsistent—only 11% of years show steady growth. The real kicker is the ROE: a mere 8.5%. That’s below my minimum threshold; I like businesses that compound capital at 15% or more. The operating margin is excellent at 36.8%, but if that can’t translate into high returns on equity, something is structurally wrong. Balance sheet is fine—low debt, excellent liquidity—but a strong balance sheet without earning power is like a well-maintained car with no engine. Free cash flow is positive, which is good, but with no dividend or buyback history (or data), I can’t judge management’s capital allocation. Ultimately, price is what you pay, value is what you get. At a market cap of $43.5 billion versus an intrinsic value near $2.9 billion, the only signal is to stay away. I’d rather wait for a severe correction that brings the stock down to levels where the margin of safety is at least 30-40%. Until then, it’s a pure avoid.

### 🔴 michael_burry_agent — BEARISH (confidence: 75%)

FCF yield 0.4%. No EV/EBIT available. Net cash but $43.5B market cap doesn't justify near-zero free cash flow. Insider buying 4.2M shares noted, but without value it's noise. Pass.

### 🔴 peter_lynch_agent — BEARISH (confidence: 65%)

I love the insider buying—50 open-market buys and not a single sale. That tells me management believes in the story. And the revenue growth of 644%? That'd catch any investor's eye. But here's the rub: the P/E is 834. Even if this company were a ten-bagger in the making, I’d need a PEG ratio under 1 to sleep at night, and with no EPS growth data and a P/E like that, the PEG is either incalculable or out of sight. The low debt and positive free cash flow are nice, but a 8.7% operating margin doesn’t scream 'wide moat.' The headlines are rosy, but I’ve learned the hard way that a stock can have a great story and still burn a hole in your pocket. I’d rather wait until the price comes down to a sensible level, even if the kids are all using their products. Right now, it’s an easy pass for me.

### 🔴 warren_buffett_agent — BEARISH (confidence: 20%)

Overvalued with margin of safety -94.9%, low score 9/27, inconsistent earnings, insufficient moat data.

### 🔴 charlie_munger_agent — BEARISH (confidence: 10%)

Poor moat, management, predictability; negative margin of safety and FCF yield.

### 🟡 nassim_taleb_agent — NEUTRAL (confidence: 55%)

Strong skin in the game and R&D convexity, but low FCF yield and severe drawdown signal fragility. Mixed signals.

### 🟡 cathie_wood_agent — NEUTRAL (confidence: 55%)

Credo Technology is at the heart of the AI data center transformation, providing high-speed SerDes and connectivity IP that are critical for scaling massive compute workloads. The revenue acceleration to 126% growth and a sky-high R&D spend of 33.4% of revenue reveal a company fully committed to innovation and riding an exponential demand curve. This is exactly the kind of disruptive technology we seek—enabling faster data movement in a world increasingly constrained by bandwidth. However, our conviction is tempered by two factors. First, while the revenue trajectory is exceptional, the innovation moat is not yet fully proven; the low score in our innovation analysis (5/15) suggests that the competitive landscape remains intense, with larger incumbents and the risk of commoditization. Second, the valuation presents a stark challenge: our DCF‑based intrinsic value of ~$2.4 billion is dwarfed by a market cap of ~$43.5 billion, implying a margin of safety of -94.5%. Such extreme pricing leaves little room for any execution misstep, even for a company with this growth profile. We need to see further evidence of durable competitive advantage, expanding TAM capture, and a pathway to profitability that justifies the current multiple before turning decisively bullish. For now, we are neutral, watching closely for signs of sustained momentum and moat‑building.

### 🟡 fundamentals_analyst_agent — NEUTRAL (confidence: 50%)

{'profitability_signal': {'signal': 'bullish', 'details': 'ROE: 27.50%, Net Margin: 31.80%, Op Margin: 36.80%'}, 'growth_signal': {'signal': 'bullish', 'details': 'Revenue Growth: 201.50%, Earnings Growth: 412.50%'}, 'financial_health_signal': {'signal': 'bearish', 'details': 'Current Ratio: N/A, D/E: N/A'}, 'price_ratios_signal': {'signal': 'bearish', 'details': 'P/E: 129.69, P/B: 23.55, P/S: 40.76'}, 'summary': '2B/2Be/0N signals → NEUTRAL. Profitability bullish (ROE: 27.50%, Net Margin: 31.80%, Op Margin: 36.80%); Growth bullish (Revenue Growth: 201.50%, Earnings Growth: 412.50%); Health bearish (Current Ratio: N/A, D/E: N/A); Valuation bearish (P/E: 129.69, P/B: 23.55, P/S: 40.76).'}

### 🟡 phil_fisher_agent — NEUTRAL (confidence: 50%)

From a Phil Fisher perspective, Credo Technology (CRDO) presents a fascinating but incomplete picture. Revenue growth of 65.2% annually is truly exceptional, signaling strong market demand and a potentially vast addressable opportunity that could support long-term expansion. The company’s commitment to innovation is evident, with an R&D investment ratio of 33.4%—among the highest I’ve seen—which, if well-directed, could yield a pipeline of future products that creates durable competitive advantages. Gross margins of 64.8% are robust, hinting at pricing power and a defendable market position. However, these strengths are tempered by significant concerns. Despite the high gross margin, operating margins have been volatile and slightly declining, and the company has yet to demonstrate consistent profitability: return on equity is a meager 7.7%, and free cash flow is erratic, often negative. This indicates that the business is still in a heavy investment phase without clear evidence that it can generate the kind of sustained, above-average returns on capital that I require. Management efficiency is therefore questionable, though the debt-to-equity ratio of 0.02 is reassuringly conservative. Valuation is a glaring red flag—P/E of over 834 and P/FCF of nearly 669 are extreme even for a high-growth company, and my willingness to pay a premium for quality would not extend to such levels without a proven track record of profitability and cash generation. On the positive side, insider activity is strikingly bullish: 50 open-market purchases and zero sales signal strong management conviction in the long-term prospects. In weighing these factors, the company exhibits the raw hallmarks of a potential growth champion—explosive revenue, heavy R&D, and aligned insiders—but lacks the consistent profitability and rational valuation that would warrant a commitment today. As a Fisher-style investor, I would maintain a neutral stance, conduct deeper scuttlebutt research to assess whether the R&D is truly productive and margins can stabilize, and wait for clearer signs that this is an exceptional company available at a sensible price.

### 🟡 stanley_druckenmiller_agent — NEUTRAL (confidence: 45%)

CRDO exhibits explosive revenue growth of 65.2% YoY and staggering price momentum of 142.6%, alongside heavy insider buying (50 buys, zero sells) — signals of powerful underlying momentum and conviction. However, valuation is dangerously stretched: trailing P/E of 834x, P/FCF of 668x, and EV/EBITDA of 722x imply that every metric is priced for perfection. With daily volatility at 6.22%, any slowdown in growth or margin disappointment could trigger a 40–50% drawdown. While the growth story is compelling, the risk-reward is not asymmetric at these levels — upside appears limited relative to the severe downside risk. Druckenmiller would demand a clear catalyst for further multiple expansion, which isn't evident. I prefer to wait for a more favorable entry or unambiguous earnings acceleration before committing capital.

### 🟡 aswath_damodaran_agent — NEUTRAL (confidence: 15%)

Credo Technology is a high-speed connectivity solutions provider, a story-driven growth company. However, with a limited operating history, key inputs for a DCF – revenue growth rate, sustainable margins, reinvestment needs, and risk parameters (beta, debt levels) – are unavailable or unreliable. The company's market cap of $43.5 billion suggests high expectations, but without historical financials to ground assumptions, any valuation is speculative. Therefore, I cannot issue a bullish or bearish signal; the stock falls into the 'too hard' pile. I remain neutral with very low confidence.

### 🟡 risk_management_agent — NEUTRAL (confidence: 0%)

{'portfolio_value': 100000.0, 'current_position_value': 0.0, 'base_position_limit_pct': 0.1, 'correlation_multiplier': 1.05, 'combined_position_limit_pct': 0.10500000000000001, 'position_limit': 10500.000000000002, 'remaining_limit': 10500.000000000002, 'available_cash': 100000.0, 'risk_adjustment': 'Volatility x Correlation adjusted: 10.5% (base 10.0%)'}
